patient outcomes

News

Bridging-the-divide-between-digital-health-potential-and-reality

Kayentis raises €7m for its digital trial engagement platfor...

French tech company Kayentis has raised €7 million in private funding that will be invested in its digital platform for clinical trials.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Oncology

IQVIA_webinar_holding_slide-07.04.20-1200x675-NEW

Unlocking health data to improve oncology outcomes

The NHS’ globally unique health data ecosystem has the potential to improve health outcomes.

White Papers

5-big-challenges-for-pharmaceutical-marketers-1200x675

5 big challenges for pharmaceutical marketers (and their age...

For the patient demanding access to the latest medicine or the healthcare professional desperate to be able to use a new advance in treatment, every extra day, week or month waiting counts.

Views & Analysis

Roche, big data and patient outcomes: the pharmaphorum podca...

In the first pharmaphorum podcast of 2020 Roche’s Conor Megaw talks about his company’s approach to big data and how some of its partnerships have been performing.

Views & Analysis

Doctor hand holding pen and talking to the patient about medication and treatment.

How people power is building patient-centric pharma

While everyone is agreed on the importance of patient-centric pharma, just one fifth of industry insiders said they knew “how” to achieve it.

Views & Analysis

What next for joint working that really improves patient out...

Joint working has become something of the norm in the last decade, but have we taken the time to step back, take stock and see if we are doing it right?

Kayentis raises €7m for its digital trial engagement platfor...

Unlocking health data to improve oncology outcomes

5 big challenges for pharmaceutical marketers (and their age...

Roche, big data and patient outcomes: the pharmaphorum podca...

How people power is building patient-centric pharma

What next for joint working that really improves patient out...

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

patient outcomes

Editor's Picks